The changing clinical picture and epidemiology of spondyloarthritis

Nature Reviews Rheumatology

Volumn 11, Issue 2, 2015, Pages 110-118

  Van Tubergen, Astrid ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASSESSMENT OF SPONDYLOARTHRITIS INTERNATIONAL SOCIETY; AXIAL SPONDYLARTHRITIS; BONE RADIOGRAPHY; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; HEALTH CARE COST; HUMAN; INCIDENCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL SPONDYLARTHRITIS; PREVALENCE; REVIEW; SPONDYLARTHRITIS; SPONDYLITIS; BLOOD; CLASSIFICATION;

HLA B27 ANTIGEN;

HLA-B27 ANTIGEN; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; PREVALENCE; SPONDYLARTHRITIS;

EID: 84923119075     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2014.181     Document Type: Review

References (73)

1. Khan, M. A. Update on spondyloarthropathies. Ann. Intern. Med. 136, 896-907 (2002).
2. Rudwaleit, M. New approaches to diagnosis and classification of axial and peripheral spondyloarthritis. Curr. Opin. Rheumatol. 22, 375-380 (2010).
3. Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann. Rheum. Dis. 68, 777-783 (2009).
4. Rudwaleit, M. et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25-31 (2011).
5. Rudwaleit, M., van der Heijde, D., Khan, M. A., Braun, J. & Sieper, J. How to diagnose axial spondyloarthritis early. Ann. Rheum. Dis. 63, 535-543 (2004).
6. van der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for AS. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361-368 (1984).
7. Amor, B., Dougados, M. & Mijiyawa, M. Criteria of the classification of spondylarthropathies [French]. Rev. Rhum. Mal. Osteoartic. 57, 85-89 (1990).
8. Dougados, M. et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 34, 1218-1227 (1991).
9. Braun, J. et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 37, 1039-1045 (1994).
10. Oostveen, J., Prevo, R., den Boer, J. & van de Laar, M. Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study. J. Rheumatol. 26, 1953-1958 (1999).
11. Pedersen, S. J., Weber, U. & Ostergaard, M. The diagnostic utility of MRI in spondyloarthritis. Best Pract. Res. Clin. Rheumatol. 26, 751-766 (2012).
12. Baeten, D., Breban, M., Lories, R., Schett, G. & Sieper, J. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum. 65, 12-20 (2013).
13. Weber, U. et al. The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum. 62, 3048-3058 (2010).
14. Aydin, S. Z. et al. Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann. Rheum. Dis. 71, 56-60 (2012).
15. Weber, U. et al. Development and validation of a magnetic resonance imaging reference criterion for defining a positive sacroiliac joint magnetic resonance imaging finding in spondyloarthritis. Arthritis Care Res. (Hoboken) 65, 977-985 (2013).
16. van den Berg, R. et al. ASAS modification of the Berlin algorithm for diagnosing axial spondyloarthritis: results from the SPondyloArthritis Caught Early (SPACE)-cohort and from the Assessment of SpondyloArthritis international Society (ASAS)-cohort. Ann. Rheum. Dis. 72, 1646-1653 (2013).
17. van den Berg, R. et al. Percentage of patients with spondyloarthritis in patients referred because of chronic back pain and performance of classification criteria: experience from the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford) 52, 1492-1499 (2013).
18. Moltó, A. et al. Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204262.
19. van der Heijde, D. et al. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 66, 667-673 (2014).
20. Rudwaleit, M. et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann. Rheum. Dis. 68, 1520-1527 (2009).
21. Rudwaleit, M. et al. The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum. 60, 717-727 (2009).
22. Kiltz, U. et al. The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study. Ann. Rheum. Dis. 71, 1207-1211 (2012).
23. Kiltz, U. et al. Do patients with non-radiographic axial spondylarthritis differ from patients with AS? Arthritis Care Res. (Hoboken) 64, 1415-1422 (2012).
24. Ciurea, A. et al. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum. 65, 3096-3106 (2013).
25. Callhoff, J., Sieper, J., Weiss, A., Zink, A. & Listing, J. Efficacy of TNFα blockers in patients with AS and non-radiographic axial spondyloarthritis: a meta-analysis. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2014-205322.
26. Landewé, R., Dougados, M., Mielants, H., van der Tempel, H. & van der Heijde, D. Physical function in AS is independently determined by both disease activity and radiographic damage of the spine. Ann. Rheum. Dis. 68, 863-867 (2009).
27. Koumakis, E. et al. Heel pain in spondyloarthritis: results of a cross-sectional study of 275 patients. Clin. Exp. Rheumatol. 30, 487-491 (2012).
28. de Carvalho, H. M. et al. Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin. Rheumatol. 31, 687-695 (2012).
29. Dougados, M. et al. A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann. Rheum. Dis. 69, 1430-1435 (2010).
30. Paramarta, J. E. et al. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without AS or psoriatic arthritis. Ann. Rheum. Dis. 72, 1793-1799 (2013).
31. Stolwijk, C., Boonen, A., Van Tubergen, A. & Reveille, J. D. Epidemiology of spondyloarthritis. Rheum. Dis. Clin. North Am. 38, 441-476 (2012).
32. Feldtkeller, E., Khan, M. A., van der Heijde, D., Van der Linden, S. & Braun, J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with AS. Rheumatol. Int. 23, 61-66 (2003).
33. Sampaio-Barros, P. D., Conde, R. A., Bonfiglioli, R., Bértolo, M. B. & Samara, A. M. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol. Int. 26, 1143-1146 (2006).
34. Marzo-Ortega, H. et al. Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence. Ann. Rheum. Dis. 68, 1721-1727 (2009).
35. Chung, H. Y., Machado, P., van der Heijde, D., D'Agostino, M. A. & Dougados, M. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis. Ann. Rheum. Dis. 70, 1930-1936 (2011).
36. Akkoc, N. Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review. Curr. Rheumatol. Rep. 10, 371-378 (2008).
37. Reveille, J. D., Witter, J. P. & Weisman, M. H. Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey. Arthritis Care Res. (Hoboken) 64, 905-910 (2012).
38. Hukuda, S. et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J. Rheumatol. 28, 554-559 (2001).
39. Boyer, G. S. et al. Prevalence of spondyloarthropathies in Alaskan Eskimos. J. Rheumatol. 21, 2292-2297 (1994).
40. Alexeeva, L. et al. Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia. J. Rheumatol. 21, 2298-2300 (1994).
41. Muñoz-Fernández, S. et al. Early spondyloarthritis: results from the pilot registry ESPIDEP. Clin. Exp. Rheumatol. 28, 498-503 (2010).
42. Bhatia, K., Prasad, M. L., Barnish, G. & Koki, G. Antigen and haplotype frequencies at three human leucocyte antigen loci (HLA-A,-B,-C) in the Pawaia of Papua New Guinea. Am. J. Phys. Anthropol. 75, 329-340 (1988).
43. Gofton, J. P., Chalmers, A., Price, G. E. & Reeve, C. E. HL-A 27 and AS in, B. C. Indians. J. Rheumatol. 11, 572-573 (1984).
44. Benevolenskaia, L. I., Erdes, S., Krylov, M. & Chekalina, N. A. The epidemiology of spondyloarthropathies among the native inhabitants of Chukotka. 2. The prevalence of HLA-B27 in the population and among spondyloarthropathy patients [Russian]. Ter Arkh 66, 41-44 (1994).
45. Gran, J. T., Mellby, A. S. & Husby, G. The prevalence of HLA-B27 in Northern Norway. Scand. J. Rheumatol. 13, 173-176 (1984).
46. Gran, J. T., Husby, G. & Hordvik, M. Prevalence of AS in males and females in a young middle-aged population of Tromso, northern Norway. Ann. Rheum. Dis. 44, 359-367 (1985).
47. Johnsen, K., Gran, J. T., Dale, K. & Husby, G. The prevalence of AS among Norwegian Samis (Lapps). J. Rheumatol. 19, 1591-1594 (1992).
48. Khan, M. A. HLA-B27 and its subtypes in world populations. Curr. Opin. Rheumatol. 7, 263-269 (1995).
49. Mustafa, K. N., Hammoudeh, M. & Khan, M. A. HLA-B27 Prevalence in Arab populations and among patients with AS. J. Rheumatol. 39, 1675-1677 (2012).
50. Costantino, F. et al. Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204436.
51. Geirsson, A. J., Eyjolfsdottir, H., Bjornsdottir, G., Kristjansson, K. & Gudbjornsson, B. Prevalence and clinical characteristics of AS in Iceland -a nationwide study. Clin. Exp. Rheumatol. 28, 333-340 (2010).
52. Carbone, L. D. et al. Ankylosing spondylitis in Rochester, Minnesota, 1935-1989 Is the epidemiology changing? Arthritis Rheum. 35, 1476-1482 (1992).
53. Bakland, G., Nossent, H. C. & Gran, J. T. Incidence and prevalence of AS in Northern Norway. Arthritis Rheum. 53, 850-855 (2005).
54. Dean, L. E. et al. Global prevalence of AS. Rheumatology (Oxford) 53, 650-657 (2014).
55. Bakland, G., Alsing, R., Singh, K. & Nossent, J. C. Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27. Arthritis Care Res. (Hoboken) 65, 448-453 (2013).
56. Strand, V. et al. Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis. Arthritis Care Res. (Hoboken) 65, 1299-1306 (2013).
57. Van Tubergen, A. & Weber, U. Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat. Rev. Rheumatol. 8, 253-261 (2012).
58. Savolainen, E., Kaipiainen-Seppanen, O., Kröger, L. & Luosujärvi, R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J. Rheumatol. 30, 2460-2468 (2003).
59. De Angelis, R., Salaffi, F. & Grassi, W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand. J. Rheumatol. 36, 14-21 (2007).
60. Townes, J. M. et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann. Rheum. Dis. 67, 1689-1696 (2008).
61. Söderlin, M. K., Borjesson, O., Kautiainen, H., Skogh, T. & Leirisalo-Repo, M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann. Rheum. Dis. 61, 911-915 (2002).
62. Saraux, A. et al. Prevalence of spondyloarthropathies in France: 2001. Ann. Rheum. Dis. 64, 1431-1435 (2005).
63. Van Hoeven, L., Luime, J., Han, H., Vergouwe, Y. & Weel, A. Identifying axial spondyloarthritis in Dutch primary care patients, ages 20-45 years, with chronic low back pain. Arthritis Care Res. (Hoboken) 66, 446-453 (2014).
64. Sieper, J. & van der Heijde, D. Review: Nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum. 65, 543-551 (2013).
65. Poddubnyy, D. et al. The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann. Rheum. Dis. 71, 1998-2001 (2012).
66. Bennett, A. N. et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident AS at eight years. Arthritis Rheum. 58, 3413-3418 (2008).
67. Poddubnyy, D. et al. Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann. Rheum. Dis. 70, 1369-1374 (2011).
68. Gong, Y. et al. Ten years' experience with needle biopsy in the early diagnosis of sacroiliitis. Arthritis Rheum. 64, 1399-1406 (2012).
69. Braun, J. et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum. 41, 58-67 (1998).
70. Haglund, E. et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann. Rheum. Dis. 70, 943-948 (2011).
71. Saraux, A. et al. Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest. J. Rheumatol. 26, 2622-2627 (1999).
72. Smolen, J. S. et al. Treating spondyloarthritis, including AS and psoriatic arthritis, to target: recommendations of an international task force. Ann. Rheum. Dis. 73, 6-16 (2014).
73. Van der Burg, L. R., Ter Wee, M. M. & Boonen, A. Effect of biological therapy on work participation in patients with AS: a systematic review. Ann. Rheum. Dis. 71, 1924-1933 (2012).